Pharma CEO Series: An Evening with Ted Love, CEO of Global Blood Therapeutics

Gibson Dunn
555 Mission St
San Francisco

Please join the Harvard Club of San Francisco in a fireside chat with Dr. Ted Love.  Co-sponsored by Johns Hopkins Alumni of Northern California, HBS Association of Northern California, and Yale Club of San Francisco

Monday, June 20, 2015
6:30 – 8:30pm

Dr. Ted Love has more than 20 years of broad leadership and management experience in the pharmaceutical industry. Dr. Love most recently served as executive vice president, research and development and technical operations at Onyx Pharmaceuticals, where he played an instrumental role in initiating and completing several of Onyx’s first Phase 3 clinical trials.

Prior to Onyx, Dr. Love served as president, chief executive officer and chairman of Nuvelo, Inc., where he led growth of the company to a market capitalization of $1 billion, and previously served as senior vice president, development at Theravance, Inc.

Earlier in his career, Dr. Love held roles of increasing responsibility in medical affairs and product development at Genentech. As vice president, product development, Dr. Love oversaw the development strategy and execution leading to approvals of Rituxan, Herceptin, Xolair, TNKase, Raptiva and Avastin.

Dr. Love has served as a consultant in medicine at Massachusetts’s General Hospital in the department of cardiology. Dr. Love currently sits on the board of directors of Amicus Therapeutics and Oncothyreon.

He holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School. Dr. Love completed his residency in internal medicine and fellowship in cardiology at the Massachusetts General Hospital.

Gibson Dunn (building doorman will open door and escort to offices)
555 Mission St, San Francisco
$25 per person

Click here to register

RSVP by June 19

Anupam Agarwal, MPH '05 and Eli Salomon HLS '06

Questions? Please contact Eli at